Progenity to Participate in the Piper Sandler 33rd Annual Virtual Healthcare Conference

Rhea-AI Summary

Progenity, Inc. (Nasdaq: PROG) will participate in a pre-recorded fireside chat at the Piper Sandler 33rd Annual Virtual Healthcare Conference. The chat will be available on November 22, 2021, starting at 10 a.m. Eastern / 7 a.m. Pacific. Additionally, Progenity will hold 1x1 investor meetings on November 30, exclusively through Piper Sandler. The company focuses on women's health, gastrointestinal health, and oral biotherapeutics, utilizing a multi-omics approach to enhance diagnostic precision and treatment efficacy.

SAN DIEGO, Nov. 15, 2021 (GLOBE NEWSWIRE) -- Progenity, Inc. (Nasdaq: PROG), an innovative biotechnology company, today announced that the company will participate in a pre-recorded fireside chat at the Piper Sandler 33rd Annual Virtual Healthcare Conference, which will be available on the conference website beginning at 10 a.m. Eastern / 7 a.m. Pacific on November 22, 2021. A link to the fireside chat will also become available at the same time in the Investors section of the company’s website at progenity.com/presentations.

Progenity will be participating in 1x1 meetings with investors on Tuesday, November 30, and meetings can be requested exclusively via Piper Sandler.

About Progenity

Progenity, Inc. is a biotechnology company innovating in the fields of women’s health, gastrointestinal health, and oral biotherapeutics. Progenity applies a multi-omics approach, combining genomics, epigenomics, proteomics, and metabolomics to its molecular testing products and to the development of a suite of investigational ingestible devices designed to provide precise diagnostic sampling and drug delivery solutions. Progenity’s vision is to transform healthcare to become more precise and personal by improving diagnoses of disease and improving patient outcomes through localized treatment with targeted therapies.

For more information visit www.progenity.com, or follow the company on LinkedIn or Twitter.

Investor Contact:
Robert Uhl
Managing Director, ICR Westwicke
ir@progenity.com
(619) 228-5886

Media Contact:
Kate Blom-Lowery
CG Life
media@progenity.com
(619) 743-6294

FAQ

When will Progenity participate in the Piper Sandler conference?

Progenity will participate in the Piper Sandler 33rd Annual Virtual Healthcare Conference on November 22, 2021.

What time is Progenity's fireside chat at the conference?

The fireside chat will be available starting at 10 a.m. Eastern / 7 a.m. Pacific.

When are the investor meetings scheduled for Progenity?

Progenity will hold 1x1 meetings with investors on November 30, 2021.

What are Progenity's main areas of focus?

Progenity focuses on women's health, gastrointestinal health, and oral biotherapeutics.

How does Progenity enhance diagnostic and treatment precision?

Progenity uses a multi-omics approach, combining genomics, epigenomics, proteomics, and metabolomics.